2Xideas’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-36,758
| Closed | -$6.79M | – | 62 |
|
|
2024
Q4 | $6.79M | Sell |
36,758
-386
| -1% | -$71.3K | 0.91% | 41 |
|
|
2024
Q3 | $7.32M | Sell |
37,144
-5,266
| -12% | -$1.04M | 0.99% | 49 |
|
|
2024
Q2 | $8.76M | Sell |
42,410
-116
| -0.3% | -$24K | 1.09% | 47 |
|
|
2024
Q1 | $11.5M | Sell |
42,526
-12,638
| -23% | -$3.42M | 1.41% | 28 |
|
|
2023
Q4 | $13M | Sell |
55,164
-3,467
| -6% | -$820K | 1.4% | 27 |
|
|
2023
Q3 | $11.5M | Buy |
58,631
+781
| +1% | +$153K | 1.27% | 30 |
|
|
2023
Q2 | $12.2M | Buy |
57,850
+9,330
| +19% | +$1.96M | 1.16% | 37 |
|
|
2023
Q1 | $9.79M | Buy |
48,520
+1,939
| +4% | +$391K | 0.94% | 55 |
|
|
2022
Q4 | $10.2M | Buy |
46,581
+9
| +0% | +$1.96K | 1.07% | 37 |
|
|
2022
Q3 | $9.17M | Sell |
46,572
-637
| -1% | -$125K | 0.97% | 32 |
|
|
2022
Q2 | $10.1M | Buy |
47,209
+4,791
| +11% | +$1.03M | 0.92% | 45 |
|
|
2022
Q1 | $12M | Buy |
42,418
+6,561
| +18% | +$1.86M | 0.85% | 54 |
|
|
2021
Q4 | $13.5M | Buy |
+35,857
| New | +$13.5M | 0.82% | 62 |
|